Τετάρτη 3 Αυγούστου 2016

MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer

Conditions:   Gastric Adenocarcinoma,;   Gastroesophageal-junction Adenocarcinoma
Interventions:   Drug: capecitabine;   Drug: Docetaxel
Sponsor:   International Group of Endovascular Oncology
Recruiting - verified August 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2aT2ex6
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου